ALN-AAT02

Alnylam seeks MHRA approval to start ALN-AAT02 phase 1/2 trial
Pharmaceutical Business Review
Thu, 10/4/18 - 06:55 pm
Alnylam
RNAi
ALN-AAT02
MHRA
UK